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1. Introduction 
Confocal neurolasermicroscopy (NLM)(Schlosser et al., 2009 (Epub)) is the current front end 
of the innovative process in neurosurgery for optimizing the operative results. Hence NLM 
is the continuance of a protracted development. Microscopic imaging technologies in 
neurosurgery invented 50 years ago revealed new strategies and possibilities for surgeons. 
These techniques were first used with magnifying lenses in research for introducing blood 
into the subarachnoid space in the region of circle of Willis in dog (Lougheed and Tom, 
1961). It was further used in cerebrovascular diseases (Jacobson et al., 1962) (Chou, 1963), 
graft interposition (Woringer and Kunlin, 1963) (Lougheed et al., 1971) and aneurysm 
surgery (Pool and Colton, 1966) (Rand and Jannetta, 1967). From studies assessing radical 
surgery in the excision of fluorescence labelled tumours (Stummer et al., 2006) (Stummer et 
al., 1998) the necessity for a high-resolution imaging technique was clearly evident. 
Intravital fluorescence microscopy was used in animal studies to investigate 
tumorangiogenesis and microcirculation (Read et al., 2001) (Vajkoczy et al., 2000).   
In the following section our pilot study using NLM in the neurosurgical operating condition 
is introduced (Schlosser et al., 2009 (Epub)). We aimed to demonstrate a technique with the 
potential to be adapted intraoperatively to define cellular and subcellular structures during 
ongoing neurosurgery. Here we show our results of miniaturized confocal lasermicroscopy 
in normal brain and brain tumor tissue which we termed NLM. Our pilot study was 
initiated to test the feasibility of this new technique and to open the door for high resolution 
imaging during ongoing neurosurgery.  
2. Technical background 
We used a miniaturized confocal laser microscope (Optiscan, Australia, Fig. 1) for tissue 
examination as described earlier (Schlosser et al., 2009 (Epub)). This technique was first 
described as confocal laser endoscopy in gastrointestinal endoscopy and was used for high-
resolution in-vivo imaging while endoscopy of the upper or lower gastrointestinal tract was 
performed (Kiesslich et al., 2004). The ability to detect or exclude premalignant conditions 
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and/or other pathologies which were normally not visible created a complete new field of 
gastrointestinal diagnosis followed by specific treatment before classical histology was 
accessible (Bojarski et al., 2009). For the use in humans intravenous applied fluorescein 
sodium distributes throughout the mucosa, however, most of the serum albumin bound 
fraction of fluorescein highlights the blood vessels and the capillaries.  
 
 
Fig. 1. Distal tip of the confocal endomicroscope EC-3870CIFK (Pentax, Europe) used in 
gastrointestinal endoscopy. As a protrusion on the end of a conventional endoscope a 
microscopic lens is mounted (diameter of the lens is 5 mm). All other features of the distal 
tip are standard in routine endoscopy.  
 
 
Fig. 2. (With kind permission of Peter Delaney, Optiscan, Australia and Ralf Kiesslich, 
University Medicine Mainz, Germany). The use of confocal endomicroscopy in human 
gastrointestinal tract. When the confocal lens was hold in gentle contact with the 
gastrointestinal mucosa, blue laser light generated a series of images every 7µm up to an 
imaging depth of 250µm. Typical contrast dyes were fluorescein and acriflavine as indicated. 
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Topically applied acriflavine hydrochloride (0.05% in saline, Sigma Aldrich, Germany) 
accentuates the superficial cell borders and their nuclei (Hoffman et al., 2006). Acriflavine is 
not approved for the use in humans due to a low but theoretical risk of inducing 
mutagenesis as described in cell culture systems (Ferenc et al., 1999). However, in special 
clinical indications there are several studies in which this substance was used safely (Leong 
et al., 2008) (Günther et al., 2010). 
3. Pilot study 
In our pilot study NLM was performed in an ex vivo approach on small tissue samples of 
patients suspicious to suffer from GBM (WHO IV, n=9) or meningeoma (grade I n=2, grade 
II n=1) after diagnostic radiology. Open tumor resection was performed in the neurosurgical 
OR in all patients. No prior histological diagnosis was available before neurosurgery. One 
sample of tumor tissue was used for direct comparison of NLM and histopathology of the 
same area. After the examination with NLM the specimen was transferred to 
neuropathology for conventional tissue examination. Additional fragments of the tumor 
center and border were analysed by NLM. Different additional fragments were sent for 
conventional pathological diagnosis. These were not marked as study material and therefore 
assessment and diagnosis was blinded.  
 
 
Fig. 3. (Removed with approval Schlosser, Cen Eur Neurosurg, 2010, 71(1):13-9) 
Histopathology and Neurolasermicroscopy (NLM) of a GBM (a-f same patient, a-c center; d-
f infiltration zone, bar = 100 µm). a, d: H&E staining of tumor border (a) and infiltration 
zone (d). H&E staining of tumor center shows a high density of tumor cells; b, e: 
immunohistochemical staining with MIB-1antibody to assess proliferation in tumor center 
(b) and infiltration zone (e). c, f: NLM of tumor center (c) and infiltration zone (f) with 
detection of a high density of tumor cells in the center and markedly reduced cell density in 
the infiltration zone. The margin of the tumor appears similar to a parabolic curve.  
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Frozen sections were done in 4 out of the 9 patients with GBM and all patients with 
meningeoma (n=3). It was beyond the scope of the present study to directly compare the 
diagnostic outcome of frozen sections, conventional histology and NLM even because all 
patients had a final histological confirmation of glioblastoma or meningeoma. However, we 
see some future indications for NLM to contribute to a rapid diagnosis intraoperatively and 
to reduce the proportion of frozen sections reasonably. 
After the tissue sample was coated with acriflavine 0.05% the NLM device was hold in 
gentle contact with the surface of the tumor and confocal scanning process was initiated. 
Histological processing included staining with hematoxylin and eosin (HE), periodic acidic 
Schiff (PAS), silver-impregnation for reticulin or immunohistochemical staining.  
Histopathology was performed according to the criteria for GBM of the recent WHO 
classification respecting the exceptions and subtypes (Louis et al., 2007). In nine patients 
with histologically proven GBM, in which no case of “small cell glioblastoma” or 
glioblastoma with oligodendroglial component” occurred, the presence of the following 
WHO criteria for GBM were analysed in the NLM obtained images: a) cell number and 
density, b) cell pleomorphy, c) mitotic figures and rate of mitosis (high, moderate, low), d) 
microvascular proliferation and e) pseudopalisading necrosis. Diagnosis and specific 
findings of NLM images and conventional histopathology were compared when all data 
were available. In three patients with histologically proven meningeoma typical features 
were visible with NLM including pleomorphy, onion-skin shaped appearance of tumor cells 
and single apoptotic cells. 
 
 
Fig. 4. (Removed with approval Schlosser, Cen Eur Neurosurg, 2010, 71(1):13-9) Histology 
(H&E; a-d, bar = 100 µm; c, bar = 50 µm) and NLM (e-h, bar = 100 µm) of WHO criteria for 
the diagnosis of GBM. a, e: tumor center with a high density of pleomorphic tumor cells. b, f: 
microvascular proliferation within the tumor formation (arrow). c, g: mitotic figures (arrows 
in c, square in g), higher magnification in g shows the mitosis within the nucleus (inset). d, 
h: pseudopalisading necrosis. 
NLM was an easy to handle tool and revealed in all nine patients with GBM and three 
patients with meningeoma typical characteristics of tumor architecture. This unique 
technique provided evaluable scans for all patients with GBM from the center and from the 
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border depicting the differences of both areas. The overall image quality was good. In one 
patient with GBM the scanning images directly correspond to conventional histopathology 
in all five diagnostic aspects. The WHO criteria for the diagnosis of GBM - cell density, cell 
pleomorphy, mitoses, microvascular proliferation and pseudopalisading or ischemic 
necrosis - were all detectable by NLM.  
Identification of the infiltration zone or the center of the tumor was possible in any patient 
by determination of the cell density comparing center and border resection bloc (Fig 3). 
Further WHO criteria for tumor classification to identify GBM were compared to histology 
in the same resection bloc and were identified in some but not all patients (Fig. 4). 
The NLM images of nine patients with histologically proven GBM were analysed for the 
presence of WHO criteria of GBM. In all 9 patients cell density and cell pleomorphy were 
clearly visible with NLM. In 44% of the patients (4/9) microvascular proliferation was 
visible and in 22% of the patients (2/9) mitosis and stroke like necrosis was identified. 
Additional aspects, e.g. apoptotic figures in perinecrotic palisading tumor cells, and 
important histological structures such as giant cells, fibrillary tumor matrix and blood 
vessels were also visible with NLM (Fig. 5). Typical features of NLM in patients with 
histologically proven meningeoma are shown in Fig. 6. 
 
 
Fig. 5. (Removed with approval Schlosser, Cen Eur Neurosurg, 2010, 71(1):13-9) Additional 
findings of GBM with NLM (bar = 100 µm). a: giant cell within the tumor formation. b: 
pathological blood vessel, the thickened wall of the  vessel is clearly visible (arrows). c: 
necrosis formation in the near of tumor cells. d: apoptotic figure within the tumor center 
(square), magnification shows characteristic chromatin fragments at the inner side of the 
nuclear membrane (inset). 
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Fig. 6. Representative NLM images from patients with histologically proven meningeoma 
(n=3, bar = 100 µm). a: tumor center with a high density of pleomorphic tumor cells in grade 
II meningeoma, b: undirected tumor cells with a pathological blood vessel (in between the 
spotted line) and neoangiogenesis (arrows) in the same patient; c: typical onion-shaped 
tumor cell configuration in grade I meningeoma (circle), d: single apoptotic cells (arrows) in 
the tumor border in the same patient.  
4. Discussion 
Neurolasermicroscopy (NLM) was shown to recognize malignant brain tumor 
characteristics in patients with histologically proven GBM in our pilot feasibility study 
(Schlosser et al., 2009 (Epub)). There was a good accordance of the NLM images compared 
to the histopathological findings with respect to the WHO classification (Louis et al., 2007). 
The differentiation of more specific tumor entities by NLM should be performed after this 
promising technique is transferred into the intraoperative situation. Our ex vivo approach 
opened the door for a neurosurgical in vivo diagnosis on a cellular and subcellular level. 
Moreover, the combination of confocal laser microscopy and flexible video systems may 
promote a variety of potential developments eligible for neurosurgical procedures. This 
ranges from process optimization in the operating room (OR) to new ways to corroborate 
regenerative therapy (Wessels et al., 2007). Current research data showed the same 
technique we use in our pilot study to be useful in patients during neurosurgery (Sanai et 
al., 2011 (Epub), Schlosser, H.G., Bojarski, C. (2011 (Epub)). Confocal Neurolasermicroscopy 
(NLM). Neurosurgery, Epub,). 
www.intechopen.com
 
Confocal Neurolasermicroscopy - Modern Perspectives for Glioma Resection on a Cellular Level 
 
393 
5. Definition of histological borders 
Realizing in vivo histology during neurosurgery would contribute to a better definition of 
the histological borders of the tumor. This would improve the definition of the resection 
margins significantly. However, due to the infiltrative growth of many primary brain 
tumours it is not possible to clearly define the exact margins of a tumor mass in all cases, 
neither by conventional histology nor by NLM. The in vivo look on these areas from tumor 
to intact brain tissue (probably by using a histopathological NLM classification) could 
provide new insights towards a standardized diagnosis during neurosurgery. 
On a cellular basis the excision could be performed as much as necessary but as little as 
possible which could be beneficial for patients suffering from a brain tumor (Lacroix et al., 
2001) (Ammirati et al., 1987). The amount of residual tumor mass after surgery is one of the 
most important prognostic factors (Burger and Green, 1987) (Wood et al., 1988). NLM scans 
on a cellular and subcellular level could be more accurate than performing the whole 
investment of brain navigation even with shift correction (Asthagiri et al., 2007).  
Regarding those aspects one has to focus on the appearance of the NLM scans depicting 
tumor pathologies. Cell types, cell division, neovascularisation and boarder zones have to 
become acquainted to the observer as well as th possibility for dynamic investigation. This 
histology is different from the appearance in classical histopathology. So neurosurgeon and 
pathologist have to share their insight and practically an atlas for defining all pathologies 
seen in NLM with regard for the process in the theatre has to be developed in the near 
future.  
6. Targeted biopsies 
Compared to conventional “random” brain tissue biopsies with the possibility of sampling 
errors NLM allowed “targeted” biopsies which could increase the reliability of the diagnosis 
when multiple cell types contribute to a tumor.  
7. Potential indications 
By using NLM the process of frozen sections could be influenced considerably. On the one 
hand thee cellular findings could be discussed between surgeon and pathologist 
demonstrating different areas and shifting the focus depending on the microscopic results 
which can affect the further direction of the procedure, on the other hand the NLM scans 
could be transferred directly to the pathologist via a network with marked reduction of the 
processing time for serial-cuts. This would also eliminate transfer time of the tissue bloc 
from the OR to the laboratory.  
8. Molecular imaging  
The presented scans show also vascular and important subcellular aspects contributing to 
the final diagnosis by predicting typical disease features. The options for biochemical or 
immunologic in vivo imaging by using antibodies or cell surface markers can be evaluated 
in the future after establishing NLM as an in vivo tool for neurosurgery providing a cellular 
and subcellular view. This subcellular view already enabled physiologic investigations in 
skin (Lademann et al., 2007) (Suihko et al., 2005). 
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9. Further developments 
The next step in evaluating NLM for a diagnostic approach in humans during ongoing 
neurosurgery would be to utilize an adapted miniaturized confocal instrument specially 
designed for neurosurgery applications. The technical settings for the laser system can be 
directly transferred from the system used in this study. However, one important problem 
should be addressed concerning the reprocessing of the microscopic device. The way of 
reprocessing will be an essential step to use the microscope in a sterile condition within 
routine neurosurgical procedures. The first data in humans during ongoing neurosurgery 
are meanwhile available (Sanai et al., 2011 (Epub), Schlosser, H.G., Bojarski, C. (2011 
(Epub)). Neurosurgery, however the problem of reprocessing is not completely fixed. The 
confocal laser technique for the reusable equipment has been licensed by Zeiss, Germany, 
for neurosurgery from its initial developer in Australia. Here the integration of NLM into a 
conventional microscope system is advanced including the option of navigation and 
matching image-guidance data. A hand-held device has been designed and used in animal 
research (Sankar et al., 2010) and in humans (Schlosser, H.G., Bojarski, C. 2011 (Epub)). For 
the reusable system used in endoscopy in the last years a setrilizablility has not been 
achieved. So the application in routine neurosurgical procedures is severely limited. One 
has to think to introduce a disposable system which is already in clinical use for different 
applications. An adaptation of a reusable system could be the step to provide a confocal 
neurolasermicroscope for routine clinical use in neurosurgery. 
Furthermore, the use of contrast agents has to be adapted to the in vivo situation. We would 
prefer using intravenously injected fluorescein (Makale, 2007) instead of topically applied 
acriflavine. Fluorescein is used for decades in ophthalmology and is permitted as a medical 
investigational drug with a very low rate of side effects (Lipson and Yannuzzi, 1989). 
Moreover, fluorescein is an established contrast agent in confocal endomicroscopy in 
gastroenterology where it distributes the entire gastrointestinal tissue up to 250 µm in depth 
(Hoffman et al., 2006). When fluorescein is applied in neurosurgery one has to consider the 
effect of passing the blood brain barrier (BBB), presumably only a small amount of serum 
albumin unbound fraction of fluorescein will pass BBB and the dye mainly stay 
intravascular. The amount of cellular staining has to be explored in further studies. In the 
neoplastic tissue the vessels probably will show a different pattern compared to healthy 
brain. We would expect abnormal branching and looping of the vasculature as well as 
abrupt changes in diameter contributing to stricture-like structures. The extravascular 
distribution of fluorescein, however, in a disturbed BBB as in neoplastic conditions may 
show the pathologic vascularisation in combination with a cellular staining.  
The next step after defining the pathologies in an NLM atlas and after ascertain the affiliated 
operative proceeding clinical studies have to proof the benefit for the patients depending on 
the disease. 
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